BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Vitetta L. Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19. J Clin Med 2021;10:2903. [PMID: 34209870 DOI: 10.3390/jcm10132903] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol 2023; 12(2): 68-90 [DOI: 10.5501/wjv.v12.i2.68] [Reference Citation Analysis]
2 Ahsan K, Anwar MA, Munawar N. Modulation of gut microbiota as a potential therapy to manipulate drug-induced hepatic damage in COVID-19 patients. World J Gastroenterol 2023; 29(11): 1708-1720 [DOI: 10.3748/wjg.v29.i11.1708] [Reference Citation Analysis]
3 Alsayed AR, Abed A, Khader HA, Al-Shdifat LMH, Hasoun L, Al-Rshaidat MMD, Alkhatib M, Zihlif M. Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment. Int J Mol Sci 2023;24. [PMID: 36835503 DOI: 10.3390/ijms24044086] [Reference Citation Analysis]
4 Ricci A, Roviello GN. Exploring the Protective Effect of Food Drugs against Viral Diseases: Interaction of Functional Food Ingredients and SARS-CoV-2, Influenza Virus, and HSV. Life (Basel) 2023;13. [PMID: 36836758 DOI: 10.3390/life13020402] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hassan D, Hossain A. Gut microbiome and COVID-19. Viral, Parasitic, Bacterial, and Fungal Infections 2023. [DOI: 10.1016/b978-0-323-85730-7.00033-3] [Reference Citation Analysis]
6 Zhang M, Chen Y, Chen R, Wen Y, Huang Q, Liu Y, Zhao C. Research status of the effects of natural oligosaccharides on glucose metabolism. eFood 2022;3. [DOI: 10.1002/efd2.54] [Reference Citation Analysis]
7 Zhu T, Jin J, Chen M, Chen Y. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review. Virulence 2022;13:1076-87. [PMID: 35763685 DOI: 10.1080/21505594.2022.2090071] [Reference Citation Analysis]
8 Rossini V, Tolosa-enguis V, Frances-cuesta C, Sanz Y. Gut microbiome and anti-viral immunity in COVID-19. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2143476] [Reference Citation Analysis]
9 Cheng X, Zhang Y, Li Y, Wu Q, Wu J, Park S, Guo C, Lu J. Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol 2022;22:274. [DOI: 10.1186/s12866-022-02686-9] [Reference Citation Analysis]
10 Li Y, Dong L, Mu Z, Liu L, Yang J, Wu Z, Pan D, Liu L. Research Advances of Lactoferrin in Electrostatic Spinning, Nano Self-Assembly, and Immune and Gut Microbiota Regulation. J Agric Food Chem 2022. [PMID: 35968926 DOI: 10.1021/acs.jafc.2c04241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Chen T, Hsu M, Lee M, Chou C. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses 2022;14:1188. [DOI: 10.3390/v14061188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
12 Xu L, Yang CS, Liu Y, Zhang X. Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis. Front Pharmacol 2022;13:895193. [DOI: 10.3389/fphar.2022.895193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther 2022;7:135. [PMID: 35461318 DOI: 10.1038/s41392-022-00974-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
14 Khan A, Rao TS, Joshi HM. Phage therapy in the Covid-19 era: Advantages over antibiotics. Curr Res Microb Sci 2022;:100115. [PMID: 35187507 DOI: 10.1016/j.crmicr.2022.100115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Akhmedov VA. Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19. Terapevticheskii arkhiv 2022;94:277-82. [DOI: 10.26442/00403660.2022.02.201388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Precup G, Pocol CB, Teleky BE, Vodnar DC. Awareness, Knowledge, and Interest about Prebiotics-A Study among Romanian Consumers. Int J Environ Res Public Health 2022;19:1208. [PMID: 35162231 DOI: 10.3390/ijerph19031208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
17 Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi LA, Shahidi Bonjar AH, Jamshidi P, Nasiri MJ, Mirsaeidi M. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Front Cell Infect Microbiol 2022;12:804644. [PMID: 35310853 DOI: 10.3389/fcimb.2022.804644] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 16.0] [Reference Citation Analysis]
18 Chen J, Vitetta L, Henson JD, Hall S. The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. J Funct Foods 2021;87:104850. [PMID: 34777578 DOI: 10.1016/j.jff.2021.104850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 García-Ricobaraza M, García-Santos JA, Escudero-Marín M, Diéguez E, Cerdó T, Campoy C. Short- and Long-Term Implications of Human Milk Microbiota on Maternal and Child Health. Int J Mol Sci 2021;22:11866. [PMID: 34769296 DOI: 10.3390/ijms222111866] [Reference Citation Analysis]